Intl Barrier Tech (IBTGF) 0.2834

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intl Barrier Tech (IBTGF) 0.2834 $IBTGF

Louisiana-Pacific Corporation (NYSE: LPX) Today Announced That It Will Add a FlameBlock(R) Fire-Rated OSB Sheathing Line at Its Clarke County, Ala., Facility
Marketwired - Tue Aug 04, 5:00PM CDT
International Barrier Technology Inc. ("Barrier" (OTCQB: IBTGF) (TSX VENTURE: IBH), a manufacturer of proprietary fire-resistant building materials, is pleased to announce that LP(R) Building Products ("LP" released news that they will begin construction of a FlameBlock line located in Clarke County, Alabama. LP FlameBlock(R) Fire-Rated OSB Sheathing will be manufactured under a Technology License Agreement with Barrier, including use of the proprietary Pyrotite(R) technology. Construction of the new line will begin in the third quarter of 2015, with completion expected by September, 2016. LP's Clarke County mill currently manufactures OSB sheathing and LP's TopNotch(R) Sub-Flooring.
LPX: 20.13 (-0.05), IBH.VN: 0.340 (+0.030)

LP to Add FlameBlock(R) Fire-Rated OSB Sheathing Line at Clarke County, Alabama OSB Mill
BusinessWire - Tue Aug 04, 4:45PM CDT
Louisiana-Pacific Corporation (NYSE: LPX) today announced that it will add a FlameBlock(R) Fire-Rated OSB Sheathing line at its Clarke County, Ala., facility.
LPX: 20.13 (-0.05)

International Barrier Technology -- Fire-Resistant Building Materials Company -- Reports Fiscal Year Record Sales Revenue of $8,428,333 and Record Sales Volume of 21,624,100 Sq. Ft. for YE June 30, 2015
Marketwired - Thu Jul 23, 8:13AM CDT
International Barrier Technology Inc. ("Barrier" (OTCQB: IBTGF) (TSX VENTURE: IBH), a manufacturer of proprietary fire-resistant building materials, has released sales revenue and sales volumes for fiscal year ending June 30, 2015.
IBH.VN: 0.340 (+0.030)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Triumph Financial Sets Stage for Q4 Earnings and Insights

Updated Category News Views 196

Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...

Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide

Updated Category News Views 6

The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...

Continue Reading
Understanding Dowlais Group's Recent Market Activities

Updated Category News Views 185

Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r

Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024

Updated Category News Views 98

OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...

Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma

Updated Category News Views 89

HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...

Continue Reading